Insider · CIK 0001278439

DENKHAUS DONALD A

Reports to the SEC for 2 companies · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001278439

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,468 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−499K sh	$31.50	−$15.7M	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−33.5K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−29.5K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,414 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,894 sh	—	—	0
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,334 sh	—	—	498,773
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,334 sh	—	—	178,163
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	179,497
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	497,439
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−947 sh	—	—	180,910
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+947 sh	—	—	496,026
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,468 sh	—	—	181,857
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+18.1K sh	—	—	176,389
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	495,079
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	158,274
2025-01-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$2.24	+$112K	491,079
2025-01-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	162,274
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	212,274
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	441,079
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	439,746
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	213,607
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+2,841 sh	—	—	215,020
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+23.2K sh	—	—	212,179
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	188,931
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	438,333
2024-02-05	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$4.01	+$160K	434,333
2024-02-05	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	192,931
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	232,931
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	394,333
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+29.5K sh	—	—	230,024
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,240 sh	—	—	234,264
2023-08-03	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+60K sh	$1.13	+$67.8K	393,000
2023-08-03	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−60K sh	—	—	200,500
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	260,500
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	333,000
2023-01-24	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$0.79	+$39.5K	329,000
2023-01-24	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	264,500
2022-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	314,500
2022-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+15K sh	—	—	310,500
2022-12-06	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,334 sh	—	—	279,000
2022-12-06	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,334 sh	—	—	295,500
2022-11-11	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−20K sh	$16.59	−$332K	277,666
2022-09-14	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	−20K sh	$15.34	−$307K	297,666
2022-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+12K sh	—	—	296,834

Recent filings

Accepted (ET)
Jul 174
DENKHAUS DONALD A0001161697-26-000175
SEC(opens sec.gov)
Dec 304
DENKHAUS DONALD A0001161697-25-000490
SEC(opens sec.gov)
Dec 104
DENKHAUS DONALD A0001161697-25-000444
SEC(opens sec.gov)
Nov 244
DENKHAUS DONALD A0001161697-25-000415
SEC(opens sec.gov)
Feb 194
DENKHAUS DONALD A0001161697-25-000066
SEC(opens sec.gov)

Companies

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134